Positive results announced for acute myeloid leukaemia treatment trial
Positive topline results have been announced from a Phase II…
Positive topline results have been announced from a Phase II trial of VENCLEXTA® (venetoclax) in combination with azacitidine in patients with acute myeloid leukaemia (AML).